Management Consulting

Market Opportunity Assessment and Growth Strategy

Actionable insights customized for your business

Find the right opportunities across Pharma, MedTech and Digital Health with Alira Health as your partner. You’ll benefit from comprehensive evaluations and action plans for market approach, access, prioritization, pricing, and challenges.

Strategy backed by research

Alira Health delivers market research based on objective data collection and analysis that targets growth, synergy, economy-of-scale, and revenue opportunities. We’re committed to delivering comprehensive, custom research that leverages a wide range of sources including:
  • Surveys and interviews from focus groups, industry experts, and key opinion leaders
  • Collaboration with clinicians, executives, hospital personnel, distributors, and administrators
  • Government, commercial markets, and global healthcare databases

Comprehensive assessment and planning

As our partner, you’ll work closely with our in-house market access and growth strategy experts to capture the full spectrum of your business goals. Together, we will:
  • Determine key capabilities to sustain and gain competitive advantages – and how to develop or acquire them
  • Map and prioritize the most promising short- and long-term growth opportunities
  • Outline value creation potential for core, adjacent and transformational opportunities in relation to current capabilities
  • Establish key success factors for selected opportunities and build high-level business cases for relevant segments
  • Identify promising targets for inorganic strategies, and, working with our Transaction Advisory practice, acquire targets

A unique four-step approach

Alira Health offers a comprehensive four-step process to identify, map, prioritize, and execute unique strategies to capitalize on market-leading opportunities.

Why choose Alira Health?

With Alira Health as your partner, you will benefit from:

  • Experience across the full healthcare ecosystem
  • Top talent from investment banks and the healthcare industry
  • Integrated market and growth strategy assessment tailored to your business goals

Related news

Events January 27, 2023
Alira Health and Biocat Startup Support Program Presentation
Biocat and Alira Health partnered to foster Market Access for startups. Alira Health, a global healthcare advisory and technology company, and Biocat, a strategic stakeholder building(...)
Market Access Startups
Publications January 20, 2023
Insights on Market Access
To get her perspective on market access and what to expect in 2023, we spoke with Nerea Blanqué, Senior Vice President of Market Access and Pricing at Alira Health.
Market Access Medical Devices Pharma
Publications December 21, 2022
2022 Recap: Your Favorite Alira Health Publications
In 2022, the Alira Health team of scientists, strategists, economists, clinicians, and biostatisticians shared actionable insights, industry thought leadership, and leading-edge guidance(...)
Clinical Digital Health Market Access MedTech Pharma Regulatory
News November 15, 2022
Alira Health Partners with Policy Matters to Foster Market Access in the UK
Alira Health, a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, announces its partnership with leading UK market access specialist(...)
Digital Health Healthcare Consulting Market Access
News November 10, 2022
Alira Health and GDMH together to boost Life Sciences innovation
The companies join forces for collaborative research and co-development of projects in the fields of Digital Health, Real-World Evidence and Market Access.
Clinical Trials Digital Health DTx Market Access Real-World Evidence RWE
Events October 7, 2022
Debate Sobre los IPT en Oncología
We are pleased to announce our next event, “Debate Sobre los IPT en Oncología,” focusing on price and reimbursement (P&R) of vital oncology and oncohematology therapies.
Market Access Product Development Regulatory
Publications October 5, 2022
Relative Weight of the Variables Evaluated Through the Therapeutic Positioning Reports in the Pricing and Reimbursement of Oncological and Oncohematology Medicines in Spain
Discover how companies’ target prices are impacted by the different variables leveraged during the P&R process for oncology and oncohematology’s first indication.
Market Access Oncology Spain
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.